The Scientific Advisory Board

Red Abbey has recruited an experienced Scientific Advisory Board comprised of distinguished thought leaders in the medical and scientific communities who have significant experience in technology and intellectual property development, biology, chemistry, genetics and drug discovery and development. Red Abbey currently has eight Senior Advisors. These individuals are a source of strategic advice and investment opportunities.

Mark Adler, MD
Founder, CEO and Medical Director of the San Diego Cancer Center

Sydney Brenner, PhD
Nobel Laureate and Distinguished Research Professor at the Salk Institute, La Jolla, California

Paul Citron
Medtronic (retired)

Sam Eletr, PhD
Interim CEO of Population Genetics, Ltd.

Jonathan Karn, PhD
Reinberger Professor of Molecular Biology and Chairman of the Department of Molecular Biology and Microbiology at the Case School of Medicine (Case Western Reserve University)

Amos B. Smith, III, PhD
Rhodes-Thompson Professor of Chemistry and Member of the Monell Chemical Senses Center at the University of Pennsylvania

Solomon H. Snyder, MD
Director of the Department of Neuroscience and Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry at the Johns Hopkins University School of Medicine

David C. U’Prichard, PhD
Senior Advisor and Venture Partner, President of Druid Consulting LLC